A citation-based method for searching scientific literature

Oliver Kloeters, Helmut Friess, Nathalia Giese, Markus W Buechler, Yalcin Cetin, Hasan Kulaksiz. Scand J Gastroenterol 2008
Times Cited: 17







List of co-cited articles
144 articles co-cited >1



Times Cited
  Times     Co-cited
Similarity


Brentuximab vedotin (SGN-35) in patients with relapsed or refractory systemic anaplastic large-cell lymphoma: results of a phase II study.
Barbara Pro, Ranjana Advani, Pauline Brice, Nancy L Bartlett, Joseph D Rosenblatt, Tim Illidge, Jeffrey Matous, Radhakrishnan Ramchandren, Michelle Fanale, Joseph M Connors,[...]. J Clin Oncol 2012
677
11

Cancer statistics, 2015.
Rebecca L Siegel, Kimberly D Miller, Ahmedin Jemal. CA Cancer J Clin 2015
11

Antibody-drug conjugates--an emerging class of cancer treatment.
Nikolaos Diamantis, Udai Banerji. Br J Cancer 2016
279
11

Antibody-drug conjugates as novel anti-cancer chemotherapeutics.
Christina Peters, Stuart Brown. Biosci Rep 2015
211
11

Site-specific conjugation of a cytotoxic drug to an antibody improves the therapeutic index.
Jagath R Junutula, Helga Raab, Suzanna Clark, Sunil Bhakta, Douglas D Leipold, Sylvia Weir, Yvonne Chen, Michelle Simpson, Siao Ping Tsai, Mark S Dennis,[...]. Nat Biotechnol 2008
809
11


Increased survival in pancreatic cancer with nab-paclitaxel plus gemcitabine.
Daniel D Von Hoff, Thomas Ervin, Francis P Arena, E Gabriela Chiorean, Jeffrey Infante, Malcolm Moore, Thomas Seay, Sergei A Tjulandin, Wen Wee Ma, Mansoor N Saleh,[...]. N Engl J Med 2013
11

Antibody-drug conjugates: current status and future directions.
Heidi L Perez, Pina M Cardarelli, Shrikant Deshpande, Sanjeev Gangwar, Gretchen M Schroeder, Gregory D Vite, Robert M Borzilleri. Drug Discov Today 2014
266
11

FOLFIRINOX versus gemcitabine for metastatic pancreatic cancer.
Thierry Conroy, Françoise Desseigne, Marc Ychou, Olivier Bouché, Rosine Guimbaud, Yves Bécouarn, Antoine Adenis, Jean-Luc Raoul, Sophie Gourgou-Bourgade, Christelle de la Fouchardière,[...]. N Engl J Med 2011
11

Lineage-specific T-cell responses to cancer mucosa antigen oppose systemic metastases without mucosal inflammatory disease.
Adam E Snook, Peng Li, Benjamin J Stafford, Elizabeth J Faul, Lan Huang, Ruth C Birbe, Alessandro Bombonati, Stephanie Schulz, Matthias J Schnell, Laurence C Eisenlohr,[...]. Cancer Res 2009
31
11

Cytokine adjuvanation of therapeutic anti-tumor immunity targeted to cancer mucosa antigens.
Adam E Snook, Lan Huang, Stephanie Schulz, Laurence C Eisenlohr, Scott A Waldman. Clin Transl Sci 2008
7
28

Cancer mucosa antigens as a novel immunotherapeutic class of tumor-associated antigen.
A E Snook, L C Eisenlohr, J L Rothstein, S A Waldman. Clin Pharmacol Ther 2007
23
11

Mucosally restricted antigens as novel immunological targets for antitumor therapy.
Adam E Snook, Benjamin J Stafford, Laurence C Eisenlohr, Jay L Rothstein, Scott A Waldman. Biomark Med 2007
10
20

Guanylate cyclase-C receptor activation: unexpected biology.
Stuart M Brierley. Curr Opin Pharmacol 2012
45
11

The paracrine hormone for the GUCY2C tumor suppressor, guanylin, is universally lost in colorectal cancer.
Chantell Wilson, Jieru E Lin, Peng Li, Adam E Snook, Jianping Gong, Takahiro Sato, Chengbao Liu, Melanie A Girondo, Hallgeir Rui, Terry Hyslop,[...]. Cancer Epidemiol Biomarkers Prev 2014
40
11

GUCY2C ligand replacement to prevent colorectal cancer.
Erik S Blomain, Amanda M Pattison, Scott A Waldman. Cancer Biol Ther 2016
12
16

Guanylyl cyclase C signaling axis and colon cancer prevention.
Amanda M Pattison, Dante J Merlino, Erik S Blomain, Scott A Waldman. World J Gastroenterol 2016
29
11

Heterogeneity of guanylyl cyclase C expressed by human colorectal cancer cell lines in vitro.
S A Waldman, M Barber, J Pearlman, J Park, R George, S J Parkinson. Cancer Epidemiol Biomarkers Prev 1998
37
11

Bile acids initiate lineage-addicted gastroesophageal tumorigenesis by suppressing the EGF receptor-AKT axis.
Li Gong, Philip R Debruyne, Matthew Witek, Karl Nielsen, Adam Snook, Jieru E Lin, Alessandro Bombonati, Juan Palazzo, Stephanie Schulz, Scott A Waldman. Clin Transl Sci 2009
8
25

Trastuzumab emtansine for HER2-positive advanced breast cancer.
Sunil Verma, David Miles, Luca Gianni, Ian E Krop, Manfred Welslau, José Baselga, Mark Pegram, Do-Youn Oh, Véronique Diéras, Ellie Guardino,[...]. N Engl J Med 2012
11

Antibody-targeted drugs and drug resistance--challenges and solutions.
LeeRon Shefet-Carasso, Itai Benhar. Drug Resist Updat 2015
67
11

A monomethyl auristatin E-conjugated antibody to guanylyl cyclase C is cytotoxic to target-expressing cells in vitro and in vivo.
Melissa Gallery, Julie Zhang, Daniel P Bradley, Pamela Brauer, Donna Cvet, Jose Estevam, Hadi Danaee, Edward Greenfield, Ping Li, Mark Manfredi,[...]. PLoS One 2018
14
14

Phase II study of the antibody-drug conjugate TAK-264 (MLN0264) in patients with metastatic or recurrent adenocarcinoma of the stomach or gastroesophageal junction expressing guanylyl cyclase C.
Khaldoun Almhanna, Maria Luisa Limon Miron, David Wright, Antonio Cubillo Gracian, Richard A Hubner, Jean-Luc Van Laethem, Carolina Muriel López, Maria Alsina, Frederico Longo Muñoz, Johanna Bendell,[...]. Invest New Drugs 2017
13
15

Cancer Statistics, 2017.
Rebecca L Siegel, Kimberly D Miller, Ahmedin Jemal. CA Cancer J Clin 2017
11


Bacterial heat-stable enterotoxins: translation of pathogenic peptides into novel targeted diagnostics and therapeutics.
Jieru E Lin, Michael Valentino, Glen Marszalowicz, Michael S Magee, Peng Li, Adam E Snook, Brian A Stoecker, Chang Chang, Scott A Waldman. Toxins (Basel) 2010
25
11

Role for the membrane receptor guanylyl cyclase-C in attention deficiency and hyperactive behavior.
Rong Gong, Cheng Ding, Ji Hu, Yao Lu, Fei Liu, Elizabeth Mann, Fuqiang Xu, Mitchell B Cohen, Minmin Luo. Science 2011
76
11

Guanylyl cyclase C messenger RNA is a biomarker for recurrent stage II colorectal cancer.
B Cagir, A Gelmann, J Park, T Fava, A Tankelevitch, E W Bittner, E J Weaver, J P Palazzo, D Weinberg, R D Fry,[...]. Ann Intern Med 1999
98
11

Epitope-targeted cytotoxic T cells mediate lineage-specific antitumor efficacy induced by the cancer mucosa antigen GUCY2C.
Adam E Snook, Michael S Magee, Glen P Marszalowicz, Stephanie Schulz, Scott A Waldman. Cancer Immunol Immunother 2012
15
13

Linaclotide activates guanylate cyclase-C/cGMP/protein kinase-II-dependent trafficking of CFTR in the intestine.
Md Kaimul Ahsan, Boris Tchernychev, Marco M Kessler, Robert M Solinga, David Arthur, Cristina I Linde, Inmaculada Silos-Santiago, Gerhard Hannig, Nadia A Ameen. Physiol Rep 2017
28
11

Two randomized trials of linaclotide for chronic constipation.
Anthony J Lembo, Harvey A Schneier, Steven J Shiff, Caroline B Kurtz, James E MacDougall, Xinwei D Jia, James Z Shao, Bernard J Lavins, Mark G Currie, Donald A Fitch,[...]. N Engl J Med 2011
230
11

Calorie-induced ER stress suppresses uroguanylin satiety signaling in diet-induced obesity.
G W Kim, J E Lin, A E Snook, A S Aing, D J Merlino, P Li, S A Waldman. Nutr Diabetes 2016
26
11

Guanylin and uroguanylin are produced by mouse intestinal epithelial cells of columnar and secretory lineage.
Pauline T Ikpa, Hein F B M Sleddens, Kris A Steinbrecher, Maikel P Peppelenbosch, Hugo R de Jonge, Ron Smits, Marcel J C Bijvelds. Histochem Cell Biol 2016
30
11

GUCY2C opposes systemic genotoxic tumorigenesis by regulating AKT-dependent intestinal barrier integrity.
Jieru Egeria Lin, Adam Eugene Snook, Peng Li, Brian Arthur Stoecker, Gilbert Won Kim, Michael Sullivan Magee, Alex Vladimir Mejia Garcia, Michael Anthony Valentino, Terry Hyslop, Stephanie Schulz,[...]. PLoS One 2012
65
11

Cyclic-GMP-Elevating Agents Suppress Polyposis in ApcMin mice by Targeting the Preneoplastic Epithelium.
Sarah K Sharman, Bianca N Islam, Yali Hou, Nagendra Singh, Franklin G Berger, Subbaramiah Sridhar, Wonsuk Yoo, Darren D Browning. Cancer Prev Res (Phila) 2018
22
11

Two distinct GUCY2C circuits with PMV (hypothalamic) and SN/VTA (midbrain) origin.
D J Merlino, J R Barton, B A Charsar, M D Byrne, J A Rappaport, R J Smeyne, A C Lepore, A E Snook, S A Waldman. Brain Struct Funct 2019
12
16

Sildenafil Suppresses Inflammation-Driven Colorectal Cancer in Mice.
Bianca N Islam, Sarah K Sharman, Yali Hou, Allison E Bridges, Nagendra Singh, Sangmi Kim, Ravindra Kolhe, Jimena Trillo-Tinoco, Paulo C Rodriguez, Franklin G Berger,[...]. Cancer Prev Res (Phila) 2017
49
11

The hormone receptor GUCY2C suppresses intestinal tumor formation by inhibiting AKT signaling.
Jieru Egeria Lin, Peng Li, Adam Eugene Snook, Stephanie Schulz, Abhijit Dasgupta, Terry Marie Hyslop, Ahmara Vivian Gibbons, Glen Marszlowicz, Giovanni Mario Pitari, Scott Arthur Waldman. Gastroenterology 2010
88
11

Congenital secretory diarrhoea caused by activating germline mutations in GUCY2C.
Thomas Müller, Insha Rasool, Peter Heinz-Erian, Eva Mildenberger, Christian Hülstrunk, Andreas Müller, Laurent Michaud, Bart G P Koot, Antje Ballauff, Julia Vodopiutz,[...]. Gut 2016
52
11

Endogenous expression of type II cGMP-dependent protein kinase mRNA and protein in rat intestine. Implications for cystic fibrosis transmembrane conductance regulator.
T Markert, A B Vaandrager, S Gambaryan, D Pöhler, C Häusler, U Walter, H R De Jonge, T Jarchau, S M Lohmann. J Clin Invest 1995
120
11

Role of cyclic GMP in the action of heat-stable enterotoxin of Escherichia coli.
J M Hughes, F Murad, B Chang, R L Guerrant. Nature 1978
350
11

Cellular localization of guanylin and uroguanylin mRNAs in human and rat duodenal and colonic mucosa.
Øystein Brenna, Marianne W Furnes, Bjørn Munkvold, Mark Kidd, Arne K Sandvik, Björn I Gustafsson. Cell Tissue Res 2016
30
11


Plecanatide-mediated activation of guanylate cyclase-C suppresses inflammation-induced colorectal carcinogenesis in Apc+/Min-FCCC mice.
Wen-Chi L Chang, Shet Masih, Anusha Thadi, Viren Patwa, Apoorva Joshi, Harry S Cooper, Vaseem A Palejwala, Margie L Clapper, Kunwar Shailubhai. World J Gastrointest Pharmacol Ther 2017
19
11




Therapeutic applications of guanylate cyclase-C receptor agonists.
Kunwar Shailubhai. Curr Opin Drug Discov Devel 2002
18
5

Guanylin peptides and colorectal cancer (CRC).
Marcello Camici. Biomed Pharmacother 2008
12
8

T84 cell receptor binding and guanyl cyclase activation by Escherichia coli heat-stable toxin.
A Guarino, M Cohen, M Thompson, K Dharmsathaphorn, R Giannella. Am J Physiol 1987
90
5


Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.